Andrew Baxter

1.5k citations

51 papers · 1.3k · h-index 24

Impact in

Physiology top 5%
- Smoking Behavior and Cessation
- Adenosine and Purinergic Signaling
Organic Chemistry top 5%
- Synthesis and biological activity

Papers in

Cancer Research 9
- Protease and Inhibitor Mechanisms 4
- Carcinogens and Genotoxicity Assessment 4
Physiology 13
- Smoking Behavior and Cessation 13

Co-authors: David Thorne (11 shared papers)Marianna Gaça (12 shared papers)Emmanuel Minet (7 shared papers)Linsey Ellen Haswell (6 shared papers)John F. Unitt (6 shared papers)Jason Adamson (5 shared papers)Doreen M. Ashworth (5 shared papers)Robert Southgate (5 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (13 papers)Journal of Medicinal Chemistry (5 papers)Scientific Reports (3 papers)Toxicology Letters (3 papers)Toxicology in Vitro (3 papers)
Partner nations: United Kingdom Sweden Switzerland

In The Last Decade

Andrew Baxter

49 papers receiving 1.1k citations

Peers

Countries citing papers authored by Andrew Baxter

Since Specialization

Citations

This map shows the geographic impact of Andrew Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Baxter more than expected).

Fields of papers citing papers by Andrew Baxter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Baxter. The network helps show where Andrew Baxter may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Baxter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Baxter Line = papers co-authored together Andrew Baxter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Andrew Baxter, Janice Bent, Keith C. Bowers, Martin Braddock, Steve Brough, Malbinder Fagura, Mandy Lawson, Tom McInally	2003	107
2	Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors Bioorganic & Medicinal Chemistry Letters ·Andrew Baxter, Steve Brough, Anne E. Cooper, Eike Floettmann, Steve Foster, Christine J Harding, Jason G. Kettle, Tom McInally	2004	78
3	2-cyanopyrrolidides as potent, stable inhibitors of dipeptidyl peptidase IV Bioorganic & Medicinal Chemistry Letters ·Doreen M. Ashworth, Butrus Atrash, Graham R. Baker, Andrew Baxter, Paul David Jenkins, D. Michael Jones, Michael Szelke	1996	68
4	Targeted omics analyses, and metabolic enzyme activity assays demonstrate maintenance of key mucociliary characteristics in long term cultures of reconstituted human airway epithelia Toxicology in Vitro ·Andrew Baxter, Simon C. Thain, Anisha Banerjee, Linsey Ellen Haswell, Aleesha Parmar, Gary J. Phillips, Emmanuel Minet	2015	56
5	Reduced biological effect of e-cigarette aerosol compared to cigarette smoke evaluated in vitro using normalized nicotine dose and RNA-seq-based toxicogenomics Scientific Reports ·Linsey Ellen Haswell, Andrew Baxter, Anisha Banerjee, Ivan Verrastro, Jessica Mushonganono, Jason Adamson, David Thorne, Marianna Gaça	2017	56
6	Novel P2X7 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Lilian Alcaraz, Andrew Baxter, Jos Bent, Keith C. Bowers, Martin Braddock, David E. Cladingboel, David K. Donald, Malbinder Fagura	2003	54
7	Hit-to-Lead studies: The discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Andrew Baxter, Anne E. Cooper, Elizabeth C. Kinchin, Kerry Moakes, John F. Unitt, A.V. Wallace	2005	47
8	The comparative in vitro assessment of e-cigarette and cigarette smoke aerosols using the γH2AX assay and applied dose measurements Toxicology Letters ·David Thorne, Sophie Larard, Andrew Baxter, Clive Meredith, Marianna Gaҫa	2016	44
9	Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Andrew Baxter, Colin Bennion, Janice Bent, Kerry Boden, Steve Brough, Anne E. Cooper, Elizabeth C. Kinchin, Nicholas D. Kindon	2003	38
10	In vitro RNA-seq-based toxicogenomics assessment shows reduced biological effect of tobacco heating products when compared to cigarette smoke Scientific Reports ·Linsey Ellen Haswell, Sarah Corke, Ivan Verrastro, Andrew Baxter, Anisha Banerjee, Jason Adamson, Tomasz Jaunky, Christopher Proctor	2018	37
11	An approach for the extract generation and toxicological assessment of tobacco-free ‘modern’ oral nicotine pouches Food and Chemical Toxicology ·Emma Bishop, N. East, Stela Bozhilova, Simone Santopietro, David E. Smart, Mark Taylor, Stuart Meredith, Andrew Baxter	2020	37
12	Total synthesis of (±)-isoprosopinine B and (±)-desoxoprosopinine Journal of the Chemical Society Chemical Communications ·Andrew B. Holmes, Andrew Baxter +2 others	1985	34
13	Application of dosimetry tools for the assessment of e-cigarette aerosol and cigarette smoke generated on two different in vitro exposure systems Chemistry Central Journal ·Jason Adamson, David Thorne, Benjamin Zainuddin, Andrew Baxter, John J. McAughey, Marianna Gaça	2016	34
14	A novel hybrid tobacco product that delivers a tobacco flavour note with vapour aerosol (Part 2): In vitro biological assessment and comparison with different tobacco-heating products Food and Chemical Toxicology ·Damien Breheny, Jason Adamson, David Azzopardi, Andrew Baxter, Emma Bishop, Tony Carr, Ian Crooks, Tomasz Jaunky	2017	32
15	Non-covalent inhibitors of rhinovirus 3C protease Bioorganic & Medicinal Chemistry Letters ·Andrew Baxter, Fredrik Edfeldt, Adrian Freeman, Cristian Johansson, Sarah J. King, Andy Morley, Jens F. W. Petersen, Phil Rawlins	2010	31
16	Discovery and synthesis of methyl 2,5-dimethyl-4-[2-(phenylmethyl)benzoyl]-1H-pyrrole-3-carboxylate (FPL 64176) and analogs: the first examples of a new class of calcium channel activator Journal of Medicinal Chemistry ·Andrew Baxter, Carol N. Manners, Simon J. Teague +2 others	1993	30
17	Peptidomimetic aminomethylene ketone inhibitors of interleukin-1β-converting enzyme (ICE) Bioorganic & Medicinal Chemistry Letters ·Graeme Semple, Doreen M. Ashworth, Andrzej R. Batt, Andrew Baxter, David W. M. Benzies, Lucy H. Elliot, Declan Evans, Richard J. Franklin	1998	29
18	Synthesis of 7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylates: the olivanic acid ring system Journal of the Chemical Society Chemical Communications ·Andrew Baxter, Kay H. Dickinson, Patricia M. Roberts, TERENCE C. SMALE, Robert Southgate	1979	28
19	PYRIDONE-BASED PEPTIDOMIMETIC INHIBITORS OF INTERLEUKIN-1β-CONVERTING ENZYME (ICE) Bioorganic & Medicinal Chemistry Letters ·Graeme Semple, Doreen M. Ashworth, Graham R. Baker, Andrzej R. Batt, Andrew Baxter, David W. M. Benzies, Lucy H. Elliot, Declan Evans	1997	26
20	CYP1A1/1B1 and CYP2A6/2A13 activity is conserved in cultures of differentiated primary human tracheobronchial epithelial cells Toxicology in Vitro ·Nik Newland, Andrew Baxter, Emmanuel Minet +1 other	2011	26

About Andrew Baxter

Andrew Baxter is a scholar working on Cancer Research, Physiology, Organic Chemistry, Computational Theory and Mathematics and Oncology, having authored 51 papers that have together received 1.3k indexed citations. Recurring topics across this work include Smoking Behavior and Cessation (13 papers), Chemical Synthesis and Analysis (5 papers), Computational Drug Discovery Methods (5 papers), Organic Chemistry Synthesis Methods (4 papers), Protease and Inhibitor Mechanisms (4 papers), Carcinogens and Genotoxicity Assessment (4 papers), Synthesis and biological activity (4 papers) and Chemokine receptors and signaling (4 papers). The work is most often cited by research in Physiology (101 citations), Physiology (295 citations), Organic Chemistry (303 citations), Cancer Research (107 citations) and Computational Theory and Mathematics (116 citations). Andrew Baxter has collaborated with scholars based in United Kingdom, Sweden and Switzerland. Frequent co-authors include David Thorne, Marianna Gaça, Emmanuel Minet, Linsey Ellen Haswell, John F. Unitt, Jason Adamson, Doreen M. Ashworth, Robert Southgate, Tom McInally and Anne E. Cooper. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Scientific Reports, Toxicology Letters and Toxicology in Vitro.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Andrew Baxter

Impact in

Papers in i

In The Last Decade

Andrew Baxter

Peers

Countries citing papers authored by Andrew Baxter

Fields of papers citing papers by Andrew Baxter

All Works

About Andrew Baxter

Explore authors with similar magnitude of impact

Papers in